The malignancy of any tumour can be measured clinically in two ways-by the duration of the untreated disease, and by the curability rate after standard treatment.
Daland, Welch and Nathanson (1936) Stout (I 932. p. 30 
1)
For the large majoritv of breast cancers the age of the woman has fittle significance. but for the extremes prognosis is definitelv affected in group statistics by the age at time of operation. In our e-xperience below the age of fortv vears axillary metastasis is much more apt to be present at the time of operation than bevond that age. In the s-ame, wav postoperative survivals. as a whole. an apparentlv cancer-fi-ee survivals are decidedlv fewer below the age of thirtv-five vears " Thus, while the number of five-year survivals in the younger age group compares favorably with those in the older group, the average duration of life for both cured and non-cured patieiits is less in the younger group. This is because of the rapid termination of fatal tumors in the young, particularly during pregnancy and lactation." Rectum.
Fowler (1926, p. (b) That if there was a correlation between age and any factor we had no reason to expect the correlation with one organ or one factor mbre than another.
The analysis of the figures therefore resolves itself into an estimation of the probability with which these figures would occur by chance if these hypotheses were true.
The collection of the data was designed so that we should be able to extract the effects due to (a) The results for the various factors were
Epidermoid differentiation : n 6 X2 4-95 P 0-7-0-5.
Glanduliform differentiation (consolidating Grades III and IV): The regression line was found by using the formula- (X -7 X) was found to be 0-000028139. This means that figures which give a regression line with this small slope might easily have occurred by chance, and there is no significant correlation between increasing-age and increasing degree of epidermoid differentiation shown by these figures.
It is to be noted, however, that the range of age-was small since there were no more sections from patients aged 30 years or less available for study, and it rnight well be that it is the,patients under 30 who give the curve its significance.
In summary we would say that there is a case for the existence of such a correlation though it cannot be very strong. DISCUSSION. Opinions in the literature on the subject are, contradictory. Certainly there is no consensus of opinion that the malignancy of cancer as estimated clinically is greater in younger patients than in older patients. As -far as we can estimate there is certainly no difference histologically. How far histological appearances are themselves correlated with growth rate and malignant behaviour in a carcinoma is, of course, a debatable matter, but in so far as they are an indication of the degree of clinical malignancy the evidence derived from them does not confirm. the belief that tumours are more malignant at young ages.
